Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)
Avalo Therapeutics' (AVTX) quarterly Inventory Average came in at $18500.0 in Q2 2023, down 22.92% YoY from $24000.0 in Q2 2022, and down 5.13% on a QoQ basis from $19500.0 in Q1 2023.
Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023) Analysis & Trends
Avalo Therapeutics (AVTX) has 6 years of Inventory Average data on file, last reported at $18500.0 in Q2 2023.
- Quarterly Inventory Average fell 22.92% year-over-year to $18500.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $18500.0 (down 22.92% YoY) and the FY2022 annual result came in at $29000.0, up 41.46% from the prior year.
- Inventory Average declined to $18500.0 in Q2 2023, from $19500.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $682452.5 in Q1 2019 to a low of $6030.0 in Q4 2020.
- A 5-year average of $80425.1 and a median of $20250.0 in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2020 — Inventory Average plunged 97.24% — and 2021, when it surged 347.76%.
- Tracing AVTX's Inventory Average over 5 years: stood at $211800.5 in 2019, then plunged by 97.15% to $6030.0 in 2020, then surged by 347.76% to $27000.0 in 2021, then decreased by 22.22% to $21000.0 in 2022, then fell by 11.9% to $18500.0 in 2023.
- The last three Inventory Average figures came in at $18500.0 (Q2 2023), $19500.0 (Q1 2023), and $21000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 18,500.00 |
| Mar 31, 2023 | 19,500.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 22,500.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 31,500.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Dec 31, 2020 | 6,030.00 |
| Sep 30, 2020 | 10,628.00 |
| Jun 30, 2020 | 14,236.00 |
| Mar 31, 2020 | 18,805.00 |
| Dec 31, 2019 | 211,800.50 |
| Mar 31, 2019 | 682,452.50 |
| Dec 31, 2018 | 691,196.00 |
| Sep 30, 2018 | 1.30 Mn |
| Jun 30, 2018 | 2.49 Mn |
| Mar 31, 2018 | 1.91 Mn |